Skip to content

Curved versus Straight Stem Uncemented Total Hip Arthroplasty. Osteoarthritis Multicenter trial.

Cu rved versus Straight Stem Uncemented Total Hip Arthroplasty. Osteoarthritis Multicenter trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24627
Enrollment
150
Registered
2008-11-25
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip avascular femoral head necrosis coxarthrose heup arthose femurkop necrose

Interventions

Curved Stemmed Total Hip Arthroplasty: CFP Stem Uncemented Straight Stemmed Total Hip Arthroplasty

Sponsors

Onze Lieve Vrouwe Gasthuis Amsterdam Oosterpark 9 Postbus 95500 1090 HM Amsterdam telephone: 0031-(0)20-5999111
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with disabling osteoarthritis of the hip who are not responding to conservative treatment for at least twelve months, who clinically fulfil the criteria to undergo a cementless total hip arthroplasty. 1. Male or female being 18 years or older 2. Patients meet the criteria for osteoarthritis: -Pain in one hip -Arthritic changes on radiograph: joint space narrowing, femoral / acetabular osteofytes, cysts and signs of sclerosis 3. Patients not responding to conservative therapy 4. Written informed consent for study participation

Exclusion criteria

Exclusion criteria: 1. Patients who are mentally impaired and not able to fill out questionnaires 2. Patients who do not know the Dutch or English or German language 3. Patients with a BMI of more than 40 4. Patients with skeletal immaturity 5. Patients with a life expectancy of less than 5 years 6. Patients with altered anatomy resulting in impossibility for the CFP procedure, according to the surgeon e.g.: -hip dysplasia with high luxation -post traumatic severe anatomic change -post-correction osteotomy 7. Patients with lower extremity amputation 8. Patients with an active malignant disease or current cytostatic treatment 9. Patients who are participating in another clinical trial 10. Known alcohol or drug abuse 11. Any condition that would impede measurement of efficacy to the opinion of the surgeon 12. Patients with a previous contralateral hip arthroplasty 13. Patients with contralateral hip pain 14. Avascular head necrosis due to sickelcel anemia

Design outcomes

Primary

MeasureTime frame
- The Dutch and the German version of the Hip disability and Osteoarthritis Outcome Score (HOOS).

Secondary

MeasureTime frame
* Composite outcome of re-operations or re-intervention Including: - Reduction of dislocation - Irrigation and debridement for infection - Open reduction of periprosthetic fractures - Revision - Bleeding / haematoma requiring surgical intervention - Any other planed or unplanned surgical intervention regarding the allocated implant. * complications Including: - Bleeding / vascular damage - Neurogenic damage - Fractures - Dislocation - Infection - Loosening - Deep venous thrombosis * Pain on a numeric rating scale (NRS) 0-10. (23) * The Short-Form (SF-36) 36 item questionnaire * The Oxford Hip Score * Position of the prosthesis: Roentgen: - Anterior Posterior pelvis roentgenogram with the feet in neutral alignment - With Zweymuller stems the holes in the trochanteric region need to be round in all x-rays. - X-hip faux profile

Contacts

Public ContactR.W. Poolman

Onze Lieve Vrouwe Gasthuis Amsterdam Department of Orthopaedic Surgery Postbus 95500

namloop@gmail.com+31 (0)20 5999111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)